Structure reports strong weight loss outcomes with oral drug

Structure Therapeutics said Monday that its investigational GLP-1 pill led to substantial weight loss in two mid-stage trials, but patients also experienced high rates of nausea and vomiting.

In the first trial, a 120-mg dose of the drug, a…